Olfactory Disorder Clinical Trial
Official title:
The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction: A Randomized Controlled Trial
Studies have demonstrated that patients with olfactory dysfunction could improve the olfactory function after olfactory training. But the efficacy of Traditional Chinese Medicine is unknown.The purpose of this study is to evaluate its efficacy in olfactory dysfunction.
Status | Recruiting |
Enrollment | 278 |
Est. completion date | December 30, 2023 |
Est. primary completion date | November 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 55 Years |
Eligibility | Inclusion Criteria: 1. Clinical diagnosis of Olfactory dysfunction; 2. 18 = age = 55 years old; 3. No active infection, such as uncontrolled pneumonia; 4. Women with reproductive potential and sexually active men agree to use acceptable and effective contraceptive methods. Exclusion Criteria: 1. Refuse to sign informed consent; 2. With other diseases that affect the result, such as severe hepatic and renal dysfunction and the investigators believes will interfere with the treatment; 3. Pregnant or lactating women; 4. Without personal freedom and independent civil capacity; 5. Enrolled in other intervention clinical trials; 6. Autoimmune diseases; 7. Other situations that the investigators think are not suitable for the trial. |
Country | Name | City | State |
---|---|---|---|
China | Eye & ENT Hospital | Shanghai | Shanghai |
Lead Sponsor | Collaborator |
---|---|
Eye & ENT Hospital of Fudan University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Questionnaire of Olfactory Disorders | every patients should answer the Questionnaire of Olfactory Disorders and record the results. The answers should be agreed, Partially agreed and disagreed. | 3 months | |
Primary | Olfactory function test result | Olfactory tests combination of odor threshold (T), odor discrimination (D), and odor identification (I). The minimum values is 0, the maximum values of odor threshold (T), discrimination (D), and identification (I) is 16, the sum of the scores is TDI, which is between 0 to 48, the higher scores mean a better outcome. | 3 months | |
Secondary | Odor threshold (T), Odor Discrimination (D), Odor Identification (I) | The scale of odor threshold (T), discrimination (D), and identification (I).The minimum values is 0, the maximum values of odor threshold (T), discrimination (D), and identification (I) is 16, the higher scores mean a better outcome. | 3 months | |
Secondary | the Visual Analogue Scale(VAS) of Olfactory Function | Participants should value their olfactory function by use the Visual Analogue Scale#VAS), the minimum values is 0, the maximum values is 10, the higher scores mean a better outcome. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04617444 -
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
|
N/A | |
Completed |
NCT02985515 -
Steroid Nasal Irrigation for Flavor Evaluation and Detection Study
|
N/A | |
Recruiting |
NCT06066307 -
Olfactory Performance in Culinary Arts Students
|
Phase 4 | |
Completed |
NCT05445921 -
Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction
|
Phase 1/Phase 2 | |
Recruiting |
NCT05855369 -
Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss
|
Phase 2/Phase 3 | |
Recruiting |
NCT03574701 -
Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL
|
N/A | |
Enrolling by invitation |
NCT04764981 -
Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)
|
N/A | |
Completed |
NCT03990766 -
Smell Changes & Efficacy of Nasal Theophylline
|
Phase 2 | |
Withdrawn |
NCT05542095 -
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
|
Phase 1 | |
Recruiting |
NCT04791436 -
Oral and Olfactory Complications of Recovered COVID-19 Patients
|
||
Enrolling by invitation |
NCT05038475 -
Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19
|
||
Completed |
NCT01332825 -
cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose
|
N/A | |
Completed |
NCT04789499 -
Smell in Covid-19 and Efficacy of Nasal Theophylline
|
Phase 2 | |
Active, not recruiting |
NCT04761458 -
Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality
|
N/A | |
Completed |
NCT04406584 -
Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction
|
N/A | |
Completed |
NCT03611673 -
At-Home Olfactory Training
|
N/A | |
Completed |
NCT04700891 -
Correlation of Preoperative Olfactory Identification Function With Frailty and Postoperative Complications and Mortality
|
N/A | |
Recruiting |
NCT04466982 -
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
|
||
Recruiting |
NCT04869436 -
Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
|
Phase 4 | |
Completed |
NCT04235153 -
CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
|